Aims-To investigate the abnormality in platelet function in two patients with type
Gaucher's disease is the most common of the lysosomal storage disorders. It is characterised by deficiency of the lysosomal enzyme glucocerebrosidase, resulting in accumulation of the sphingolipid glucocerebroside in the plasma and cells of the reticuloendothelial system.' It is autosomal recessive and comprises three types, characterised by the age of onset and degree of involvement of the nervous system. Type 1 or chronic non-neuronopathic Gaucher's disease is the most common form, with a particularly high incidence (1 in 600 to 1 in 2500) among Ashkenazim (Polish and German Jews). It is characterised by often massive splenomegaly with hypersplenism and pancytopenia.
Pathologically lipid-laden macrophagesthe Gaucher cells-are found in the red pulp of the spleen, liver sinusoids, and the bone marrow. Plasma concentrations of glucocerebroside are raised 2-to 10-fold, and in the spleen grossly raised 10-1000 fold. ' Diagnosis has typically been by enzyme assay in peripheral blood leucocytes or tissue fibroblasts. With Blood was collected from the two patients on three separate occasions into EDTA for full blood and platelet counts (STK S, Coulter Electronics, Florida, USA) and into 3*13% trisodium citrate in a ratio of 9 parts blood to 1 part trisodium citrate, for coagulation and platelet function studies. Control plasma and platelets were similarly collected from normal male volunteers. Prothrombin time (PT), thrombin time (TIT), and activated partial thromboplastin time (APPT) were performed by routine techniques.6 Factor VIIIc was assayed by a one stage automated method, von Willebrand factor antigen (vWF:Ag) by ELISA, and ristocetin cofactor activity (vWF:RiCoF) by platelet agglutination. Von Willebrand multimers were assessed by sodium dodecyl sulphate gel electrophoresis, as described before6 and platelet nucleotides (adenosine triphosphate, adenosine diphosphate; total and releasable) using a luciferase firefly luminescence technique.6 Platelet glycoproteins (GP) Ib and IIb/IIIa, platelet surface immunoglobulin, and free platelet bindable immunoglobulin were assessed by a fluorescence flow cytometric method. 7 Bleeding time was assessed with a template method and platelet aggregometry6 performed in a four channel aggregometer using the following agonists: ristocetin (Lundbeck, Luton, England) 1-25, 1-0, 0.7, 0-5 mg/ml; ADP (Sigma Chemical Co Ltd, Poole, Dorset) 5-0, 2-5, 1.0, 0-5 umol/l; collagen (Hormon Chemie, Munich, Germany) 4 0, 1 0,ug/ml; and arachidonate (Sigma) 1-0 pM. Porcine FVIII complex (Porton, Maidenhead, Berkshire) and cryoprecipitate were used in correction studies with ristocetin.
In mixing experiments washed platelets were used (three washes in Tyrodes buffer with 10 mM EDTA and 10 ng/ml prostacyclin analogue (ZK36 374 Schering Chemicals) and then resuspended in 1:4 human albumin with Tyrodes buffer, as described before.6 Patient and control platelets were then incubated with patient or control plasma and agglutination to ristocetin tested immediately and after 1 hour of incubation at room temperature. Immunoglobulin G fractions of patient and control sera were isolated by affinity chromatography using a protein G column, eluted with glycine HC1 buffer (pH 2 8), and then dialysed against phosphate buffered saline (pH 7'2) to give a final concentration of 5-10 mg/ml. IgG fractions were incubated with washed platelets for one hour and cryoprecipitate then added before testing ristocetin induced agglutination.
Results
Both patients had normal platelet counts and initial clotting screens (table). The bleeding time was >15 minutes in both cases. Platelet aggregation responses to adenosine diphosphate, collagen, and arachidonic acid were normal (table). Ristocetin induced agglutination was absent at all concentrations tested. This did not correct with procine F VIII, or cryoprecipitate and ristocetin, and there was no agglutination on the addition of cryoprecipitate alone (representative traces fig 1A) . Factor VIIIc and vWF:Ag and vWF:RiCoF activities were normal (table) .
Platelet surface glycoproteins Ib and IIb/IIIa were present in normal amounts on both patients' platelets. Free platelet bindable immunoglobulin was detected in both patient sera, and platelet surface immunoglobulin was raised in the second patient. This immunoglobulin reacted with Bemard-Soulier platelets in both cases (results not shown).
The response of washed normal platelets to ristocetin was abolished after 1 hour of incubation in patient plasma ( fig 1B) . This inhibitory activity was not present in the IgG fraction of patient sera (fig 2A) 
